02:55 PM EDT, 03/20/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month price target by $1 to $18, based on 8.4x our FY 27 (Jan.) EPS estimate and above the company's three-year average forward P/E multiple of 6.7x. We maintain our FY 27 EPS estimate of $2.15 and initiate our FY 28 EPS estimate at $2.20. We believe Macy's deserves a peer multiple as the company's plans to close Macy's locations comes to an end. M reported normalized Q4 FY 26 EPS of $1.67 vs. $1.80 in the year prior, $0.11 above consensus estimates, on total revenue of $7.92B vs. $8.00B and $131M above consensus. The company experienced comparable store sales growth across each of its nameplates, while gross margin remained stable. By nameplate in Q4, Macy's revenues declined 3.2% Y/Y, Bloomingdale's increased 8.5%, and Bluemercury increased 2.5%. Macy's comparable store sales increased 0.4%, Bloomingdale's increased 9.9%, and Bluemercury increased 1.3%. We raise our opinion as valuation no longer looks distorted (8.4x consensus next 12-month EPS estimates).